Joincare Pharmaceutical Group Industry Co Ltd (600380) — Cash Flow Reinvestment Rate
Joincare Pharmaceutical Group Industry Co Ltd (600380) has a Cash Flow Reinvestment Rate of 0.14x as of September 2025, reinvesting CN¥155.85 Million (capex CN¥155.85 Million ) from operating cash flow of CN¥1.09 Billion. See cash generation quality of Joincare Pharmaceutical Group Industry C to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Joincare Pharmaceutical Group Industry Co Ltd Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Joincare Pharmaceutical Group Industry Co Ltd across 27 annual periods. For the full cash flow conversion analysis, see how efficiently does Joincare Pharmaceutical Group Industry C generate cash.
Annual Cash Flow Reinvestment Rate for Joincare Pharmaceutical Group Industry Co Ltd (1999–2025)
Year-by-year capital reinvestment analysis for Joincare Pharmaceutical Group Industry Co Ltd. See Joincare Pharmaceutical Group Industry C leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.53x | CN¥2.06 Billion | CN¥3.89 Billion | CN¥767.20 Million | ▲ +71.7% |
| 2024 | 0.31x | CN¥1.12 Billion | CN¥3.64 Billion | CN¥979.13 Million | ▼ -39.6% |
| 2023 | 0.51x | CN¥2.01 Billion | CN¥3.93 Billion | CN¥1.13 Billion | ▼ -14.5% |
| 2022 | 0.60x | CN¥2.38 Billion | CN¥3.98 Billion | CN¥1.15 Billion | ▼ -27.1% |
| 2021 | 0.82x | CN¥2.10 Billion | CN¥2.56 Billion | CN¥1.52 Billion | ▲ +141.9% |
| 2020 | 0.34x | CN¥1.03 Billion | CN¥3.02 Billion | CN¥830.41 Million | ▼ -69.6% |
| 2019 | 1.11x | CN¥2.58 Billion | CN¥2.31 Billion | CN¥703.20 Million | ▼ -28.6% |
| 2018 | 1.56x | CN¥2.85 Billion | CN¥1.83 Billion | CN¥655.02 Million | ▲ +151.6% |
| 2017 | 0.62x | CN¥1.16 Billion | CN¥1.87 Billion | CN¥480.68 Million | ▼ -54.2% |
| 2016 | 1.35x | CN¥2.23 Billion | CN¥1.64 Billion | CN¥499.99 Million | ▲ +107.5% |
| 2015 | 0.65x | CN¥825.16 Million | CN¥1.26 Billion | CN¥594.33 Million | ▼ -21.8% |
| 2014 | 0.83x | CN¥816.97 Million | CN¥979.46 Million | CN¥816.97 Million | ▼ -46.1% |
| 2013 | 1.55x | CN¥983.83 Million | CN¥635.52 Million | CN¥983.83 Million | ▲ +31.7% |
| 2012 | 1.18x | CN¥863.48 Million | CN¥734.36 Million | CN¥863.48 Million | ▲ +73.8% |
| 2011 | 0.68x | CN¥440.12 Million | CN¥650.36 Million | CN¥440.12 Million | ▲ +28.0% |
| 2010 | 0.53x | CN¥584.47 Million | CN¥1.11 Billion | CN¥584.47 Million | ▲ +4.4% |
| 2009 | 0.51x | CN¥306.87 Million | CN¥605.66 Million | CN¥306.87 Million | ▲ +5.9% |
| 2008 | 0.48x | CN¥217.71 Million | CN¥455.01 Million | CN¥217.71 Million | ▼ -16.7% |
| 2007 | 0.57x | CN¥246.63 Million | CN¥429.26 Million | CN¥246.63 Million | ▼ -68.1% |
| 2006 | 1.80x | CN¥490.19 Million | CN¥272.50 Million | CN¥490.19 Million | ▲ +77.6% |
| 2005 | 1.01x | CN¥367.73 Million | CN¥363.13 Million | CN¥367.73 Million | ▲ +11.3% |
| 2004 | 0.91x | CN¥219.90 Million | CN¥241.71 Million | CN¥219.90 Million | ▲ +41.7% |
| 2003 | 0.64x | CN¥110.60 Million | CN¥172.25 Million | CN¥110.60 Million | ▲ +64.6% |
| 2002 | 0.39x | CN¥92.09 Million | CN¥236.13 Million | CN¥92.09 Million | ▲ +25.5% |
| 2001 | 0.31x | CN¥69.55 Million | CN¥223.79 Million | CN¥69.55 Million | ▼ -23.2% |
| 2000 | 0.40x | CN¥69.46 Million | CN¥171.61 Million | CN¥69.46 Million | ▼ -9.6% |
| 1999 | 0.45x | CN¥49.15 Million | CN¥109.82 Million | CN¥49.15 Million | — |